Posttransplantation diabetes: a systematic review of the literature

VM Montori, A Basu, PJ Erwin, JA Velosa… - Diabetes …, 2002 - Am Diabetes Assoc
OBJECTIVES—To systematically review the incidence of posttransplantation diabetes
(PTD), risk factors for its development, prognostic implications, and optimal management …

[HTML][HTML] Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature

R Shapiro, VP Scantlebury, ML Jordan… - Transplantation …, 1997 - ncbi.nlm.nih.gov
DISCUSSION The diabetogenicity of tacrolimus appears to be related to a reversible effect
of tacrolimus on islet cells. FK binding protein (FKBP) is present in islet cells, and decreased …

[PDF][PDF] Posttransplant diabetes in pediatric recipients on tacrolimus

R Shapiro, V Scantlebury, ML Jordan, C Vivas… - …, 1999 - d-scholarship.pitt.edu
We read with interest the report by Moxey-Mims et aI.," Increased Incidence of Insulin-
Dependent Diabetes Mellitus in Pediatric Renal Transplant Patients Receiving Tacrolimus …

Cost evaluation of basiliximab treatment for renal transplant patients in Japan

T Hasegawa, H Imai, S Miki - Pharmacoeconomics, 2003 - Springer
Background: International phase III studies (CRIB 201 and 352) showed that basiliximab, a
high affinity chimeric monoclonal antibody interleukin-2 receptor antagonist, is highly …

A comparative study of FK506 granules and capsules in renal transplant recipients

S Takahara, T Miki, M Hatori, Y Kokado, J Wang… - Transplant …, 1998 - Springer
Nine renal transplant recipients in stable systemic condition on FK506 capsules were
converted to FK506 granules in order to investigate the safety, efficacy, and …